MET exon 14 skipping analogs: Rare but potentially clinically actionable.

Feldman, R; Ellis, M; Swensen, J; Korn, WM; Gatalica, Z

JOURNAL OF CLINICAL ONCOLOGY, 2019; 37 (15):